Rank | Gene Set | Z-score |
---|---|---|
1 | very-low-density lipoprotein particle assembly (GO:0034379) | 5.57295754 |
2 | plasma lipoprotein particle assembly (GO:0034377) | 5.29174599 |
3 | negative regulation of fibrinolysis (GO:0051918) | 5.22195677 |
4 | protein-lipid complex assembly (GO:0065005) | 4.98355681 |
5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.77575857 |
6 | regulation of protein activation cascade (GO:2000257) | 4.65885029 |
7 | regulation of complement activation (GO:0030449) | 4.61864732 |
8 | regulation of fibrinolysis (GO:0051917) | 4.56997523 |
9 | negative regulation of protein activation cascade (GO:2000258) | 4.53488088 |
10 | low-density lipoprotein particle remodeling (GO:0034374) | 4.47939117 |
11 | negative regulation of complement activation (GO:0045916) | 4.10403012 |
12 | protein carboxylation (GO:0018214) | 4.02906098 |
13 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.02906098 |
14 | intestinal cholesterol absorption (GO:0030299) | 3.96667054 |
15 | cholesterol efflux (GO:0033344) | 3.94501906 |
16 | plasma lipoprotein particle organization (GO:0071827) | 3.76583831 |
17 | regulation of apoptotic cell clearance (GO:2000425) | 3.71988528 |
18 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.71305494 |
19 | protein-lipid complex subunit organization (GO:0071825) | 3.69021438 |
20 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.66770574 |
21 | regulation of cholesterol homeostasis (GO:2000188) | 3.65795264 |
22 | growth hormone receptor signaling pathway (GO:0060396) | 3.57656704 |
23 | plasma lipoprotein particle remodeling (GO:0034369) | 3.56347615 |
24 | protein-lipid complex remodeling (GO:0034368) | 3.56347615 |
25 | macromolecular complex remodeling (GO:0034367) | 3.56347615 |
26 | negative regulation of humoral immune response (GO:0002921) | 3.54316879 |
27 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.53321951 |
28 | regulation of cholesterol esterification (GO:0010872) | 3.51666011 |
29 | positive regulation of histone deacetylation (GO:0031065) | 3.46063682 |
30 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.43140441 |
31 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.43140441 |
32 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.22939650 |
33 | complement activation, alternative pathway (GO:0006957) | 3.21669368 |
34 | detection of molecule of bacterial origin (GO:0032490) | 3.21475156 |
35 | intestinal absorption (GO:0050892) | 3.21238864 |
36 | pinocytosis (GO:0006907) | 3.20144049 |
37 | positive regulation of blood coagulation (GO:0030194) | 3.18139120 |
38 | positive regulation of hemostasis (GO:1900048) | 3.18139120 |
39 | positive regulation of extracellular matrix organization (GO:1903055) | 3.17830346 |
40 | plasma lipoprotein particle clearance (GO:0034381) | 3.17326551 |
41 | regulation of humoral immune response (GO:0002920) | 3.17005974 |
42 | embryonic process involved in female pregnancy (GO:0060136) | 3.16819971 |
43 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.14778851 |
44 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.13481628 |
45 | high-density lipoprotein particle remodeling (GO:0034375) | 3.10558240 |
46 | blood coagulation, intrinsic pathway (GO:0007597) | 3.07899008 |
47 | negative regulation of cell killing (GO:0031342) | 3.05407593 |
48 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.05407593 |
49 | cellular response to growth hormone stimulus (GO:0071378) | 3.05179767 |
50 | regulation of extracellular matrix disassembly (GO:0010715) | 3.03664331 |
51 | cellular response to ethanol (GO:0071361) | 3.01492448 |
52 | regulation of gamma-delta T cell activation (GO:0046643) | 3.00285404 |
53 | lipoprotein metabolic process (GO:0042157) | 2.99581855 |
54 | positive regulation of coagulation (GO:0050820) | 2.98491002 |
55 | acute-phase response (GO:0006953) | 2.96061510 |
56 | protein localization to endosome (GO:0036010) | 2.95937178 |
57 | phospholipid efflux (GO:0033700) | 2.92447192 |
58 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.90935664 |
59 | regulation of extracellular matrix organization (GO:1903053) | 2.87889884 |
60 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.85608516 |
61 | reverse cholesterol transport (GO:0043691) | 2.83298184 |
62 | negative regulation of granulocyte differentiation (GO:0030853) | 2.78344160 |
63 | positive thymic T cell selection (GO:0045059) | 2.77041861 |
64 | regulation of bile acid biosynthetic process (GO:0070857) | 2.76750282 |
65 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.75200733 |
66 | mitotic sister chromatid cohesion (GO:0007064) | 2.74222788 |
67 | lipoprotein transport (GO:0042953) | 2.73543274 |
68 | low-density lipoprotein particle clearance (GO:0034383) | 2.72951946 |
69 | diacylglycerol metabolic process (GO:0046339) | 2.70946299 |
70 | substrate-dependent cell migration (GO:0006929) | 2.70097868 |
71 | positive regulation of macrophage cytokine production (GO:0060907) | 2.68800767 |
72 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.68678232 |
73 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.68678232 |
74 | modulation by symbiont of host immune response (GO:0052553) | 2.68678232 |
75 | positive regulation by symbiont of host defense response (GO:0052509) | 2.68678232 |
76 | modulation by symbiont of host defense response (GO:0052031) | 2.68678232 |
77 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.68678232 |
78 | COPII vesicle coating (GO:0048208) | 2.67653685 |
79 | negative regulation of sterol transport (GO:0032372) | 2.67439901 |
80 | negative regulation of cholesterol transport (GO:0032375) | 2.67439901 |
81 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.67272282 |
82 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.66761379 |
83 | apoptotic cell clearance (GO:0043277) | 2.66243706 |
84 | oligosaccharide catabolic process (GO:0009313) | 2.65430946 |
85 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.64898030 |
86 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.61295134 |
87 | cell adhesion mediated by integrin (GO:0033627) | 2.61056304 |
88 | definitive hemopoiesis (GO:0060216) | 2.60808436 |
89 | corticosteroid receptor signaling pathway (GO:0031958) | 2.60426910 |
90 | NLS-bearing protein import into nucleus (GO:0006607) | 2.56783638 |
91 | negative regulation of fatty acid transport (GO:2000192) | 2.56511594 |
92 | positive regulation of phagocytosis (GO:0050766) | 2.56103304 |
93 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.55642926 |
94 | positive regulation of steroid metabolic process (GO:0045940) | 2.54861321 |
95 | regulation of plasminogen activation (GO:0010755) | 2.54672193 |
96 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.53901957 |
97 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.53555412 |
98 | protein activation cascade (GO:0072376) | 2.53494382 |
99 | cortical actin cytoskeleton organization (GO:0030866) | 2.51808514 |
100 | sterol transport (GO:0015918) | 2.51192953 |
101 | cholesterol transport (GO:0030301) | 2.51192953 |
102 | germ cell migration (GO:0008354) | 2.50888264 |
103 | phospholipid homeostasis (GO:0055091) | 2.49839732 |
104 | regulation of macrophage cytokine production (GO:0010935) | 2.48481621 |
105 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.47656540 |
106 | positive regulation of chemokine secretion (GO:0090197) | 2.47279877 |
107 | detection of external biotic stimulus (GO:0098581) | 2.46427987 |
108 | negative thymic T cell selection (GO:0045060) | 2.46311225 |
109 | thymic T cell selection (GO:0045061) | 2.44502343 |
110 | negative T cell selection (GO:0043383) | 2.43589968 |
111 | regulation of chemokine secretion (GO:0090196) | 2.43490632 |
112 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.42451015 |
113 | L-phenylalanine metabolic process (GO:0006558) | 2.42451015 |
114 | fibrinolysis (GO:0042730) | 2.41880820 |
115 | complement activation, classical pathway (GO:0006958) | 2.40868933 |
116 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.40680971 |
117 | mannose metabolic process (GO:0006013) | 2.40443319 |
118 | regulation of cholesterol storage (GO:0010885) | 2.39017724 |
119 | negative regulation of blood coagulation (GO:0030195) | 2.38922683 |
120 | negative regulation of hemostasis (GO:1900047) | 2.38922683 |
121 | response to interleukin-15 (GO:0070672) | 2.36985730 |
122 | histone H3-K36 demethylation (GO:0070544) | 2.36882877 |
123 | L-phenylalanine catabolic process (GO:0006559) | 2.35622571 |
124 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.35622571 |
125 | establishment of endothelial barrier (GO:0061028) | 2.35468036 |
126 | positive regulation of transforming growth factor beta production (GO:0071636) | 2.33715589 |
127 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.32549958 |
128 | hepatocyte apoptotic process (GO:0097284) | 2.31823241 |
129 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.31706822 |
130 | endothelial tube morphogenesis (GO:0061154) | 2.31309785 |
131 | morphogenesis of an endothelium (GO:0003159) | 2.31309785 |
132 | positive T cell selection (GO:0043368) | 2.30793560 |
133 | natural killer cell differentiation (GO:0001779) | 2.29436828 |
134 | negative regulation of phagocytosis (GO:0050765) | 2.27750519 |
135 | positive regulation of lamellipodium assembly (GO:0010592) | 2.25872827 |
136 | T cell selection (GO:0045058) | 2.25823114 |
137 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.25599921 |
138 | nerve growth factor signaling pathway (GO:0038180) | 2.25465729 |
139 | positive regulation of B cell differentiation (GO:0045579) | 2.25061588 |
140 | peptidyl-lysine dimethylation (GO:0018027) | 2.24325798 |
141 | positive regulation of protein deacetylation (GO:0090312) | 2.22841421 |
142 | leukocyte tethering or rolling (GO:0050901) | 2.22177395 |
143 | cell-substrate junction assembly (GO:0007044) | 2.21788350 |
144 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.21294241 |
145 | angiogenesis involved in wound healing (GO:0060055) | 2.17586691 |
146 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.17301608 |
147 | leukocyte cell-cell adhesion (GO:0007159) | 2.16950704 |
148 | stress fiber assembly (GO:0043149) | 2.15908656 |
149 | cellular response to interferon-alpha (GO:0035457) | 2.14319671 |
150 | hypotonic response (GO:0006971) | 2.13600210 |
151 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.13431225 |
152 | nuclear pore complex assembly (GO:0051292) | 2.13371372 |
153 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.13117803 |
154 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.12219256 |
155 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.10025017 |
156 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.09770490 |
157 | plasma membrane repair (GO:0001778) | 2.09267718 |
158 | regulation of T cell tolerance induction (GO:0002664) | 2.09267221 |
159 | leukocyte aggregation (GO:0070486) | 2.08672946 |
160 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.07980425 |
161 | cortical cytoskeleton organization (GO:0030865) | 2.07280000 |
162 | macrophage activation involved in immune response (GO:0002281) | 2.07113218 |
163 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.06526304 |
164 | hemidesmosome assembly (GO:0031581) | 2.06516347 |
165 | cellular response to zinc ion (GO:0071294) | 2.05423453 |
166 | positive regulation of interferon-alpha production (GO:0032727) | 2.05124517 |
167 | coronary vasculature morphogenesis (GO:0060977) | 2.04937051 |
168 | cellular extravasation (GO:0045123) | 2.04123168 |
169 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.00721591 |
170 | axon extension involved in axon guidance (GO:0048846) | 2.00712337 |
171 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.00712337 |
172 | interferon-gamma production (GO:0032609) | 2.00410446 |
173 | regulation of interferon-alpha production (GO:0032647) | 1.99911831 |
174 | embryonic camera-type eye morphogenesis (GO:0048596) | 1.98338907 |
175 | positive regulation of p38MAPK cascade (GO:1900745) | 1.98295679 |
176 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 1.98054832 |
177 | response to host defenses (GO:0052200) | 1.98054832 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 4.41969826 |
2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.39623860 |
3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.15507628 |
4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.11367906 |
5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.93404528 |
6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.84689412 |
7 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.81038785 |
8 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.72825265 |
9 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.71768075 |
10 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 2.65583201 |
11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.62076061 |
12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.57032421 |
13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.50986161 |
14 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.48885113 |
15 | MYC_22102868_ChIP-Seq_BL_Human | 2.33433564 |
16 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.28564032 |
17 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.19232915 |
18 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.19116265 |
19 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.17326122 |
20 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.16665018 |
21 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.16218338 |
22 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.12141974 |
23 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.06575697 |
24 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.02666318 |
25 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.94516469 |
26 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.94010459 |
27 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.88943282 |
28 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.87719336 |
29 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.87520431 |
30 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.82775980 |
31 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.81464602 |
32 | GATA1_22025678_ChIP-Seq_K562_Human | 1.80004385 |
33 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.78745805 |
34 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.76113187 |
35 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.72613216 |
36 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.72082817 |
37 | MAF_26560356_Chip-Seq_TH1_Human | 1.71000539 |
38 | MYB_26560356_Chip-Seq_TH2_Human | 1.70883708 |
39 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.67471875 |
40 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.64842591 |
41 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.64722856 |
42 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.63780144 |
43 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.63659855 |
44 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.62848483 |
45 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.61948195 |
46 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.61479058 |
47 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.60633170 |
48 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.60545824 |
49 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.58683393 |
50 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.58062899 |
51 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.56303823 |
52 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.55934386 |
53 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.54690772 |
54 | SPI1_23127762_ChIP-Seq_K562_Human | 1.53760604 |
55 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.51773623 |
56 | UTX_26944678_Chip-Seq_JUKART_Human | 1.48515618 |
57 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.47885745 |
58 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.46291010 |
59 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.45293664 |
60 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.43973985 |
61 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.43298509 |
62 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.41157297 |
63 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.40439124 |
64 | MYB_26560356_Chip-Seq_TH1_Human | 1.39175397 |
65 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.38489429 |
66 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.37939343 |
67 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.37522694 |
68 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.36610227 |
69 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.36610227 |
70 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.36248184 |
71 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.35811802 |
72 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.32927539 |
73 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.30873354 |
74 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.30134691 |
75 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.29717087 |
76 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.27691745 |
77 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.27690132 |
78 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.27194613 |
79 | * TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.25526611 |
80 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.25481197 |
81 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.24507785 |
82 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.24304084 |
83 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.23611554 |
84 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.23237032 |
85 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.22570874 |
86 | GATA2_19941826_ChIP-Seq_K562_Human | 1.21589844 |
87 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.20832694 |
88 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.20805352 |
89 | CJUN_26792858_Chip-Seq_BT549_Human | 1.20418953 |
90 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.19572481 |
91 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.19118266 |
92 | GATA1_19941826_ChIP-Seq_K562_Human | 1.18356507 |
93 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.17873555 |
94 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.17502976 |
95 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16775461 |
96 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.16746814 |
97 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.16600819 |
98 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.16302096 |
99 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.16199089 |
100 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.15908005 |
101 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.15226310 |
102 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.14143186 |
103 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.13649601 |
104 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11441229 |
105 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.11026154 |
106 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.10180177 |
107 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.10148713 |
108 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.08605874 |
109 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.08555785 |
110 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.08301690 |
111 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.07303248 |
112 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.07222061 |
113 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.07222061 |
114 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.07189178 |
115 | KDM2B_26808549_Chip-Seq_K562_Human | 1.07118551 |
116 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.06973332 |
117 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.06287386 |
118 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05455388 |
119 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.04008726 |
120 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.03706683 |
121 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 1.02542733 |
122 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.02191801 |
123 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.01706535 |
124 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.01062590 |
125 | RXR_22108803_ChIP-Seq_LS180_Human | 1.00255481 |
126 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00164646 |
127 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.99552300 |
128 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.99285452 |
129 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.98293409 |
130 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.97726225 |
131 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.96875364 |
132 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.95696157 |
133 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.95694507 |
134 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95261679 |
135 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94440753 |
136 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.89762042 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 3.63480699 |
2 | MP0003300_gastrointestinal_ulcer | 3.49405576 |
3 | MP0005451_abnormal_body_composition | 3.33549445 |
4 | MP0003705_abnormal_hypodermis_morpholog | 3.09056453 |
5 | MP0003303_peritoneal_inflammation | 3.05576487 |
6 | MP0000569_abnormal_digit_pigmentation | 2.81986823 |
7 | MP0010352_gastrointestinal_tract_polyps | 2.77724081 |
8 | MP0005076_abnormal_cell_differentiation | 2.70945933 |
9 | MP0005365_abnormal_bile_salt | 2.51440204 |
10 | MP0002166_altered_tumor_susceptibility | 2.39788819 |
11 | MP0003172_abnormal_lysosome_physiology | 2.38428481 |
12 | MP0003566_abnormal_cell_adhesion | 2.23588804 |
13 | MP0005360_urolithiasis | 2.19075660 |
14 | MP0009278_abnormal_bone_marrow | 2.15614862 |
15 | MP0003195_calcinosis | 2.11954518 |
16 | MP0002006_tumorigenesis | 2.05609112 |
17 | MP0010234_abnormal_vibrissa_follicle | 2.05536988 |
18 | MP0001666_abnormal_nutrient_absorption | 2.04111218 |
19 | MP0005085_abnormal_gallbladder_physiolo | 2.00521346 |
20 | MP0003656_abnormal_erythrocyte_physiolo | 1.99189874 |
21 | MP0010329_abnormal_lipoprotein_level | 1.98698664 |
22 | MP0008438_abnormal_cutaneous_collagen | 1.97818250 |
23 | MP0004130_abnormal_muscle_cell | 1.92800997 |
24 | MP0004185_abnormal_adipocyte_glucose | 1.91721400 |
25 | MP0003122_maternal_imprinting | 1.91710660 |
26 | MP0004808_abnormal_hematopoietic_stem | 1.90984479 |
27 | MP0003252_abnormal_bile_duct | 1.89393416 |
28 | MP0002877_abnormal_melanocyte_morpholog | 1.88018316 |
29 | MP0003828_pulmonary_edema | 1.82911388 |
30 | MP0005409_darkened_coat_color | 1.80428773 |
31 | MP0003436_decreased_susceptibility_to | 1.75081799 |
32 | MP0006054_spinal_hemorrhage | 1.69936132 |
33 | MP0005275_abnormal_skin_tensile | 1.68453335 |
34 | MP0001835_abnormal_antigen_presentation | 1.66203279 |
35 | MP0009840_abnormal_foam_cell | 1.63856485 |
36 | MP0001879_abnormal_lymphatic_vessel | 1.60568787 |
37 | MP0003045_fibrosis | 1.59841377 |
38 | MP0010368_abnormal_lymphatic_system | 1.56697499 |
39 | MP0004947_skin_inflammation | 1.54786219 |
40 | MP0001545_abnormal_hematopoietic_system | 1.53673046 |
41 | MP0005397_hematopoietic_system_phenotyp | 1.53673046 |
42 | MP0003868_abnormal_feces_composition | 1.53392054 |
43 | MP0000685_abnormal_immune_system | 1.52366352 |
44 | MP0000733_abnormal_muscle_development | 1.50490252 |
45 | MP0003448_altered_tumor_morphology | 1.46178414 |
46 | MP0010307_abnormal_tumor_latency | 1.45901457 |
47 | MP0005408_hypopigmentation | 1.45852772 |
48 | MP0003091_abnormal_cell_migration | 1.43264155 |
49 | MP0000609_abnormal_liver_physiology | 1.43204059 |
50 | MP0002009_preneoplasia | 1.42752338 |
51 | MP0005666_abnormal_adipose_tissue | 1.40549025 |
52 | MP0005671_abnormal_response_to | 1.39293525 |
53 | MP0002396_abnormal_hematopoietic_system | 1.38359276 |
54 | MP0003950_abnormal_plasma_membrane | 1.37047949 |
55 | MP0010155_abnormal_intestine_physiology | 1.36630493 |
56 | MP0009780_abnormal_chondrocyte_physiolo | 1.34964341 |
57 | MP0005164_abnormal_response_to | 1.34830729 |
58 | MP0005387_immune_system_phenotype | 1.34218025 |
59 | MP0001790_abnormal_immune_system | 1.34218025 |
60 | MP0008961_abnormal_basal_metabolism | 1.34103313 |
61 | MP0001800_abnormal_humoral_immune | 1.33308589 |
62 | MP0002452_abnormal_antigen_presenting | 1.33055646 |
63 | MP0005000_abnormal_immune_tolerance | 1.32165869 |
64 | MP0009333_abnormal_splenocyte_physiolog | 1.30235315 |
65 | MP0008260_abnormal_autophagy | 1.29598084 |
66 | MP0009785_altered_susceptibility_to | 1.29194042 |
67 | MP0004883_abnormal_blood_vessel | 1.27931899 |
68 | MP0003724_increased_susceptibility_to | 1.27579406 |
69 | MP0003763_abnormal_thymus_physiology | 1.26367380 |
70 | MP0001533_abnormal_skeleton_physiology | 1.25872558 |
71 | MP0001873_stomach_inflammation | 1.25827205 |
72 | MP0000604_amyloidosis | 1.25716888 |
73 | MP0002419_abnormal_innate_immunity | 1.25134547 |
74 | MP0005375_adipose_tissue_phenotype | 1.24696001 |
75 | MP0004272_abnormal_basement_membrane | 1.24049684 |
76 | MP0002405_respiratory_system_inflammati | 1.23671270 |
77 | MP0002420_abnormal_adaptive_immunity | 1.21712346 |
78 | MP0001819_abnormal_immune_cell | 1.21490580 |
79 | MP0008469_abnormal_protein_level | 1.21150975 |
80 | MP0002132_abnormal_respiratory_system | 1.19708876 |
81 | MP0004264_abnormal_extraembryonic_tissu | 1.16638094 |
82 | MP0005025_abnormal_response_to | 1.15949699 |
83 | * MP0002998_abnormal_bone_remodeling | 1.15009232 |
84 | MP0003279_aneurysm | 1.14806539 |
85 | MP0002723_abnormal_immune_serum | 1.14154655 |
86 | MP0004510_myositis | 1.14036701 |
87 | MP0000858_altered_metastatic_potential | 1.13476931 |
88 | MP0005464_abnormal_platelet_physiology | 1.12227124 |
89 | MP0002398_abnormal_bone_marrow | 1.10700062 |
90 | MP0000003_abnormal_adipose_tissue | 1.10188983 |
91 | MP0005167_abnormal_blood-brain_barrier | 1.09585107 |
92 | MP0002118_abnormal_lipid_homeostasis | 1.09362167 |
93 | MP0005023_abnormal_wound_healing | 1.07749026 |
94 | MP0008875_abnormal_xenobiotic_pharmacok | 1.05088903 |
95 | MP0009115_abnormal_fat_cell | 1.03394116 |
96 | MP0003191_abnormal_cellular_cholesterol | 1.03004218 |
97 | MP0001958_emphysema | 1.02864524 |
98 | MP0008004_abnormal_stomach_pH | 1.00967761 |
99 | MP0003866_abnormal_defecation | 0.99785863 |
100 | MP0001849_ear_inflammation | 0.99746401 |
101 | MP0000343_altered_response_to | 0.99328111 |
102 | MP0000465_gastrointestinal_hemorrhage | 0.98971858 |
103 | MP0005670_abnormal_white_adipose | 0.98574406 |
104 | MP0002933_joint_inflammation | 0.98455861 |
105 | MP0003690_abnormal_glial_cell | 0.95908106 |
106 | MP0000716_abnormal_immune_system | 0.94337334 |
107 | MP0000767_abnormal_smooth_muscle | 0.94276419 |
108 | MP0010678_abnormal_skin_adnexa | 0.92458563 |
109 | MP0010630_abnormal_cardiac_muscle | 0.91969348 |
110 | MP0002925_abnormal_cardiovascular_devel | 0.91530164 |
111 | MP0003453_abnormal_keratinocyte_physiol | 0.90272757 |
112 | MP0000703_abnormal_thymus_morphology | 0.88803832 |
113 | MP0000598_abnormal_liver_morphology | 0.88329241 |
114 | MP0003075_altered_response_to | 0.87928880 |
115 | MP0000689_abnormal_spleen_morphology | 0.87446861 |
116 | MP0000249_abnormal_blood_vessel | 0.86918691 |
117 | MP0001851_eye_inflammation | 0.86155193 |
118 | MP0001845_abnormal_inflammatory_respons | 0.84999807 |
119 | MP0004084_abnormal_cardiac_muscle | 0.84752002 |
120 | MP0005319_abnormal_enzyme/_coenzyme | 0.83677625 |
121 | MP0000383_abnormal_hair_follicle | 0.82900361 |
122 | MP0002148_abnormal_hypersensitivity_rea | 0.82325888 |
123 | MP0002722_abnormal_immune_system | 0.81992597 |
124 | MP0000371_diluted_coat_color | 0.81946021 |
125 | MP0001853_heart_inflammation | 0.81304330 |
126 | MP0002138_abnormal_hepatobiliary_system | 0.80842280 |
127 | MP0005058_abnormal_lysosome_morphology | 0.79715426 |
128 | MP0002089_abnormal_postnatal_growth/wei | 0.78158865 |
129 | MP0002086_abnormal_extraembryonic_tissu | 0.77827813 |
130 | MP0001915_intracranial_hemorrhage | 0.77661356 |
131 | MP0002128_abnormal_blood_circulation | 0.76725803 |
132 | MP0002971_abnormal_brown_adipose | 0.75516039 |
133 | MP0005248_abnormal_Harderian_gland | 0.75292091 |
134 | MP0002429_abnormal_blood_cell | 0.75263944 |
135 | MP0004087_abnormal_muscle_fiber | 0.74687909 |
136 | MP0000013_abnormal_adipose_tissue | 0.74118911 |
137 | MP0006082_CNS_inflammation | 0.73039449 |
138 | MP0003183_abnormal_peptide_metabolism | 0.72823096 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 6.86613324 |
2 | Abnormality of the common coagulation pathway (HP:0010990) | 4.55782498 |
3 | Hypobetalipoproteinemia (HP:0003563) | 4.27830952 |
4 | Prolonged partial thromboplastin time (HP:0003645) | 4.08292947 |
5 | Joint hemorrhage (HP:0005261) | 3.84989666 |
6 | Complement deficiency (HP:0004431) | 3.73163560 |
7 | Gingival bleeding (HP:0000225) | 3.59500343 |
8 | Hematochezia (HP:0002573) | 3.33183936 |
9 | Flat acetabular roof (HP:0003180) | 3.28878893 |
10 | Acanthocytosis (HP:0001927) | 3.26922646 |
11 | Aortic aneurysm (HP:0004942) | 3.24798342 |
12 | Glomerulonephritis (HP:0000099) | 3.19847459 |
13 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.18647095 |
14 | Cerebral aneurysm (HP:0004944) | 3.15915345 |
15 | Abnormality of complement system (HP:0005339) | 3.08689269 |
16 | Gastrointestinal infarctions (HP:0005244) | 3.01669347 |
17 | Hemorrhage of the eye (HP:0011885) | 2.99239638 |
18 | Xanthomatosis (HP:0000991) | 2.97146856 |
19 | Menorrhagia (HP:0000132) | 2.95735899 |
20 | Systemic lupus erythematosus (HP:0002725) | 2.85039626 |
21 | Hypolipoproteinemia (HP:0010981) | 2.83017370 |
22 | Increased density of long bones (HP:0006392) | 2.82320025 |
23 | Subacute progressive viral hepatitis (HP:0006572) | 2.81466166 |
24 | Hypercholesterolemia (HP:0003124) | 2.81377263 |
25 | Abnormality of the fingertips (HP:0001211) | 2.81209944 |
26 | Spontaneous abortion (HP:0005268) | 2.68677315 |
27 | Peritonitis (HP:0002586) | 2.64598107 |
28 | Eczematoid dermatitis (HP:0000976) | 2.60834924 |
29 | Conjugated hyperbilirubinemia (HP:0002908) | 2.60808082 |
30 | Mitral valve prolapse (HP:0001634) | 2.59324401 |
31 | Protrusio acetabuli (HP:0003179) | 2.55814232 |
32 | Macroorchidism (HP:0000053) | 2.53859839 |
33 | Epistaxis (HP:0000421) | 2.52519227 |
34 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.52328762 |
35 | Spinal cord lesions (HP:0100561) | 2.49081359 |
36 | Syringomyelia (HP:0003396) | 2.49081359 |
37 | Abnormality of macrophages (HP:0004311) | 2.46575001 |
38 | Absent frontal sinuses (HP:0002688) | 2.45897899 |
39 | Thrombophlebitis (HP:0004418) | 2.43534735 |
40 | Vascular calcification (HP:0004934) | 2.41926781 |
41 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.41117495 |
42 | Abnormality of carpal bone ossification (HP:0006257) | 2.40170100 |
43 | Papillary thyroid carcinoma (HP:0002895) | 2.39037965 |
44 | Amyloidosis (HP:0011034) | 2.37458124 |
45 | Purpura (HP:0000979) | 2.37138897 |
46 | Dilatation of the ascending aorta (HP:0005111) | 2.35265486 |
47 | Thoracolumbar scoliosis (HP:0002944) | 2.34457828 |
48 | Aortic dissection (HP:0002647) | 2.33621226 |
49 | Osteolytic defects of the hand bones (HP:0009699) | 2.32561162 |
50 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.32561162 |
51 | Abnormal tarsal ossification (HP:0008369) | 2.31810748 |
52 | Pulmonary embolism (HP:0002204) | 2.31440677 |
53 | Short 4th metacarpal (HP:0010044) | 2.29233328 |
54 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.29233328 |
55 | Abnormality of the peritoneum (HP:0002585) | 2.28296837 |
56 | Shallow orbits (HP:0000586) | 2.27639675 |
57 | Autoimmune thrombocytopenia (HP:0001973) | 2.27220021 |
58 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.26527232 |
59 | Abnormal foot bone ossification (HP:0010675) | 2.24812409 |
60 | Persistence of primary teeth (HP:0006335) | 2.24690545 |
61 | Mitral stenosis (HP:0001718) | 2.24474678 |
62 | Recurrent bacterial skin infections (HP:0005406) | 2.23348356 |
63 | Cardiovascular calcification (HP:0011915) | 2.18263454 |
64 | Joint swelling (HP:0001386) | 2.15107929 |
65 | Striae distensae (HP:0001065) | 2.14698058 |
66 | Episodic fever (HP:0001954) | 2.13006955 |
67 | Small epiphyses (HP:0010585) | 2.12921587 |
68 | Hyperacusis (HP:0010780) | 2.12758604 |
69 | Spondylolisthesis (HP:0003302) | 2.12757637 |
70 | Polycythemia (HP:0001901) | 2.12413008 |
71 | Disinhibition (HP:0000734) | 2.12377586 |
72 | Fat malabsorption (HP:0002630) | 2.11778363 |
73 | Arterial thrombosis (HP:0004420) | 2.10635596 |
74 | Recurrent fungal infections (HP:0002841) | 2.09198588 |
75 | T lymphocytopenia (HP:0005403) | 2.08561675 |
76 | Esophageal varix (HP:0002040) | 2.07193640 |
77 | Arterial tortuosity (HP:0005116) | 2.07038693 |
78 | Aneurysm (HP:0002617) | 2.06281207 |
79 | Increased connective tissue (HP:0009025) | 2.05816051 |
80 | Myositis (HP:0100614) | 2.04391614 |
81 | Long eyelashes (HP:0000527) | 2.03300449 |
82 | Periodontitis (HP:0000704) | 2.02303458 |
83 | Skin nodule (HP:0200036) | 2.01934791 |
84 | Bicuspid aortic valve (HP:0001647) | 2.01491109 |
85 | Epidermoid cyst (HP:0200040) | 2.01072643 |
86 | Hepatocellular carcinoma (HP:0001402) | 2.00466301 |
87 | Keratoconjunctivitis sicca (HP:0001097) | 1.99498159 |
88 | Broad alveolar ridges (HP:0000187) | 1.99452004 |
89 | Interstitial pulmonary disease (HP:0006530) | 1.98764769 |
90 | Acute myeloid leukemia (HP:0004808) | 1.98449481 |
91 | Thin bony cortex (HP:0002753) | 1.98360840 |
92 | Mucopolysacchariduria (HP:0008155) | 1.97871899 |
93 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.97871899 |
94 | Abnormality of T cell number (HP:0011839) | 1.97817982 |
95 | Recurrent viral infections (HP:0004429) | 1.93982922 |
96 | Ankle contracture (HP:0006466) | 1.92346412 |
97 | Gingivitis (HP:0000230) | 1.91644560 |
98 | Dislocated radial head (HP:0003083) | 1.91631939 |
99 | Abnormal ossification of hand bones (HP:0005921) | 1.91530193 |
100 | Enlarged penis (HP:0000040) | 1.90538916 |
101 | Poikilocytosis (HP:0004447) | 1.90488337 |
102 | Toxemia of pregnancy (HP:0100603) | 1.90477797 |
103 | Cupped ribs (HP:0000887) | 1.90124554 |
104 | Orchitis (HP:0100796) | 1.90070308 |
105 | Vasculitis (HP:0002633) | 1.88013331 |
106 | Acute hepatic failure (HP:0006554) | 1.86495812 |
107 | Arthropathy (HP:0003040) | 1.85547315 |
108 | * Narrow palate (HP:0000189) | 1.85508286 |
109 | Fatigue (HP:0012378) | 1.85336503 |
110 | Asymmetry of the thorax (HP:0001555) | 1.84107487 |
111 | Abnormality of the 4th metacarpal (HP:0010012) | 1.83850868 |
112 | Cellulitis (HP:0100658) | 1.83454428 |
113 | Nephritis (HP:0000123) | 1.82895734 |
114 | Vascular tortuosity (HP:0004948) | 1.82763681 |
115 | Myocardial infarction (HP:0001658) | 1.81667077 |
116 | Exercise-induced myalgia (HP:0003738) | 1.80893916 |
117 | Dysostosis multiplex (HP:0000943) | 1.80859961 |
118 | Pulmonary infiltrates (HP:0002113) | 1.80652848 |
119 | Abnormal hand bone ossification (HP:0010660) | 1.79837677 |
120 | Flared iliac wings (HP:0002869) | 1.79768057 |
121 | Recurrent skin infections (HP:0001581) | 1.79714555 |
122 | Spontaneous hematomas (HP:0007420) | 1.79236482 |
123 | Vertebral arch anomaly (HP:0008438) | 1.78962018 |
124 | Chest pain (HP:0100749) | 1.77946643 |
125 | Broad metatarsal (HP:0001783) | 1.76635499 |
126 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.76429573 |
127 | Abnormal platelet volume (HP:0011876) | 1.75258859 |
128 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.75257350 |
129 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.75257350 |
130 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.75257350 |
131 | Type 1 muscle fiber predominance (HP:0003803) | 1.74815985 |
132 | Glomerulopathy (HP:0100820) | 1.74289406 |
133 | Gangrene (HP:0100758) | 1.73662710 |
134 | Keratoconjunctivitis (HP:0001096) | 1.73461519 |
135 | Urethral obstruction (HP:0000796) | 1.73278695 |
136 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.72842541 |
137 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.72388221 |
138 | Abnormality of oral frenula (HP:0000190) | 1.72087840 |
139 | Papilledema (HP:0001085) | 1.71645630 |
140 | Pustule (HP:0200039) | 1.71614925 |
141 | Viral hepatitis (HP:0006562) | 1.70512011 |
142 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.70360963 |
143 | Thrombocytosis (HP:0001894) | 1.69816563 |
144 | Volvulus (HP:0002580) | 1.69579951 |
145 | Hypoalphalipoproteinemia (HP:0003233) | 1.68764898 |
146 | Frequent falls (HP:0002359) | 1.68359666 |
147 | Increased mean platelet volume (HP:0011877) | 1.68336919 |
148 | Metaphyseal irregularity (HP:0003025) | 1.67916968 |
149 | Dysmetric saccades (HP:0000641) | 1.66292038 |
150 | Milia (HP:0001056) | 1.64802138 |
151 | Exostoses (HP:0100777) | 1.64769911 |
152 | Camptodactyly of toe (HP:0001836) | 1.64485351 |
153 | Deep philtrum (HP:0002002) | 1.64433384 |
154 | Recurrent abscess formation (HP:0002722) | 1.63449683 |
155 | Difficulty running (HP:0009046) | 1.60963985 |
156 | Retrobulbar optic neuritis (HP:0100654) | 1.60334679 |
157 | Optic neuritis (HP:0100653) | 1.60334679 |
158 | * Rectal prolapse (HP:0002035) | 1.59823222 |
159 | Ankyloglossia (HP:0010296) | 1.58865891 |
160 | Gastrointestinal inflammation (HP:0004386) | 1.57174406 |
161 | Hyporeflexia of lower limbs (HP:0002600) | 1.56578374 |
162 | Renal duplication (HP:0000075) | 1.55383753 |
163 | Ureteral stenosis (HP:0000071) | 1.54766448 |
164 | Increased IgE level (HP:0003212) | 1.54375024 |
165 | Ureteral obstruction (HP:0006000) | 1.54132205 |
166 | Cervical subluxation (HP:0003308) | 1.53991632 |
167 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.53725431 |
168 | Atrophic scars (HP:0001075) | 1.52712869 |
169 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.51994376 |
170 | Increased cerebral lipofuscin (HP:0011813) | 1.51708624 |
171 | Disproportionate tall stature (HP:0001519) | 1.51371163 |
172 | Slender build (HP:0001533) | 1.51357205 |
173 | Prolonged bleeding time (HP:0003010) | 1.51266728 |
174 | Abnormality of the right ventricle (HP:0001707) | 1.50987925 |
175 | Subaortic stenosis (HP:0001682) | 1.50479759 |
176 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.50479759 |
177 | Lymphangioma (HP:0100764) | 1.49956082 |
178 | Radial bowing (HP:0002986) | 1.49607186 |
179 | Inflammation of the large intestine (HP:0002037) | 1.49432460 |
180 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.48398295 |
181 | Hypercortisolism (HP:0001578) | 1.47985248 |
182 | Abnormality of the nasal mucosa (HP:0000433) | 1.47892473 |
183 | Gastrointestinal carcinoma (HP:0002672) | 1.47684158 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TRIB3 | 3.73303597 |
2 | EEF2K | 2.79618980 |
3 | PKN2 | 2.66041976 |
4 | RIPK1 | 2.64123424 |
5 | CAMK1D | 2.27861757 |
6 | MAP4K1 | 2.26312428 |
7 | TTN | 2.24128456 |
8 | PRPF4B | 2.21375973 |
9 | CDK12 | 2.00184677 |
10 | JAK3 | 1.98583723 |
11 | PTK6 | 1.98286834 |
12 | CAMK1G | 1.96117015 |
13 | MAP2K3 | 1.88389011 |
14 | IRAK3 | 1.87036070 |
15 | CDK6 | 1.82048600 |
16 | MAP3K13 | 1.79162207 |
17 | MAP3K10 | 1.76091661 |
18 | SIK1 | 1.74818507 |
19 | TGFBR2 | 1.71520670 |
20 | LATS1 | 1.69316149 |
21 | JAK1 | 1.69124487 |
22 | DMPK | 1.58020297 |
23 | LRRK2 | 1.55171632 |
24 | STK10 | 1.54015411 |
25 | SCYL2 | 1.54006842 |
26 | TXK | 1.44190612 |
27 | FRK | 1.43639780 |
28 | PDGFRA | 1.42744913 |
29 | BLK | 1.38943840 |
30 | NEK9 | 1.37087482 |
31 | TAOK1 | 1.33302023 |
32 | AKT3 | 1.32011298 |
33 | FGR | 1.31491743 |
34 | ZAP70 | 1.27842989 |
35 | ERN1 | 1.26755284 |
36 | YES1 | 1.26318067 |
37 | RPS6KA4 | 1.24200295 |
38 | * FGFR3 | 1.23603231 |
39 | MAPK11 | 1.22709341 |
40 | PDGFRB | 1.21684523 |
41 | RET | 1.17779359 |
42 | PRKAA2 | 1.15204497 |
43 | TYK2 | 1.14587038 |
44 | NLK | 1.13008333 |
45 | EPHB1 | 1.11408770 |
46 | STK3 | 1.11347665 |
47 | PRKCH | 1.10637471 |
48 | ITK | 1.10533426 |
49 | JAK2 | 1.10081000 |
50 | FGFR4 | 1.10028384 |
51 | IRAK4 | 1.08635558 |
52 | MAP3K3 | 1.07590553 |
53 | MAP3K14 | 1.06923048 |
54 | BMX | 1.05351847 |
55 | OBSCN | 1.05031864 |
56 | ALK | 1.00970263 |
57 | HCK | 1.00844085 |
58 | MAP2K6 | 1.00168138 |
59 | PIK3CG | 0.99545481 |
60 | SGK3 | 0.99284658 |
61 | CDC42BPA | 0.99136115 |
62 | TRPM7 | 0.98624268 |
63 | BMPR2 | 0.98101422 |
64 | WNK4 | 0.95963367 |
65 | SIK2 | 0.95158974 |
66 | TYRO3 | 0.95114520 |
67 | EPHA3 | 0.94416596 |
68 | CAMKK2 | 0.94386080 |
69 | MAP3K2 | 0.93375497 |
70 | CSK | 0.92034009 |
71 | TGFBR1 | 0.90757132 |
72 | MTOR | 0.88824544 |
73 | RIPK4 | 0.87168482 |
74 | TBK1 | 0.86787165 |
75 | CDK9 | 0.85925900 |
76 | STK24 | 0.85676390 |
77 | FES | 0.85220771 |
78 | MAP3K7 | 0.84922004 |
79 | KIT | 0.83704826 |
80 | TAOK3 | 0.83564506 |
81 | MARK3 | 0.82564336 |
82 | IRAK1 | 0.81834622 |
83 | PAK4 | 0.79685878 |
84 | SMG1 | 0.79171600 |
85 | CHUK | 0.78371550 |
86 | LMTK2 | 0.72143324 |
87 | * PDK1 | 0.71354108 |
88 | TIE1 | 0.70890644 |
89 | EPHB2 | 0.69210639 |
90 | BTK | 0.68813704 |
91 | * PDPK1 | 0.68427646 |
92 | GRK6 | 0.68276013 |
93 | CDK4 | 0.67772358 |
94 | MATK | 0.66866278 |
95 | LCK | 0.65079392 |
96 | DYRK1B | 0.64823877 |
97 | IKBKE | 0.64369390 |
98 | PAK2 | 0.62211935 |
99 | FGFR2 | 0.61850036 |
100 | MAPK12 | 0.60380999 |
101 | PTK2 | 0.60210094 |
102 | ICK | 0.59789939 |
103 | PIK3CA | 0.58463199 |
104 | CAMKK1 | 0.58351779 |
105 | RPS6KA2 | 0.58183817 |
106 | LYN | 0.56574863 |
107 | CSF1R | 0.56382908 |
108 | HIPK2 | 0.55236776 |
109 | SGK223 | 0.54969105 |
110 | SGK494 | 0.54969105 |
111 | TEC | 0.53296222 |
112 | SGK1 | 0.52698128 |
113 | FER | 0.52453752 |
114 | EGFR | 0.51667447 |
115 | PIM1 | 0.50072335 |
116 | IRAK2 | 0.46082273 |
117 | SYK | 0.45524342 |
118 | IGF1R | 0.45152123 |
119 | MAP3K8 | 0.44266110 |
120 | NEK2 | 0.43878070 |
121 | WNK1 | 0.43709454 |
122 | KSR2 | 0.43356372 |
123 | BRD4 | 0.42678490 |
124 | PRKD1 | 0.42502756 |
125 | MARK2 | 0.42181558 |
126 | SGK2 | 0.41965134 |
127 | MAP3K5 | 0.41523122 |
128 | DDR2 | 0.40984938 |
129 | MAPKAPK3 | 0.40285836 |
130 | MST1R | 0.39819952 |
131 | PRKG2 | 0.39381260 |
132 | MAP3K1 | 0.39307719 |
133 | MELK | 0.39258866 |
134 | ERBB2 | 0.37492095 |
135 | NEK6 | 0.35711272 |
136 | STK39 | 0.35637949 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.84528947 |
2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.62276383 |
3 | Other glycan degradation_Homo sapiens_hsa00511 | 2.47330639 |
4 | Leishmaniasis_Homo sapiens_hsa05140 | 1.93189381 |
5 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.90380583 |
6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.81158095 |
7 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.65734234 |
8 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.62608519 |
9 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.60974788 |
10 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.53860836 |
11 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.52725560 |
12 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.50977218 |
13 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.46164326 |
14 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.46003098 |
15 | Viral myocarditis_Homo sapiens_hsa05416 | 1.45328907 |
16 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.42087455 |
17 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.41443943 |
18 | Platelet activation_Homo sapiens_hsa04611 | 1.41292836 |
19 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.40683127 |
20 | Focal adhesion_Homo sapiens_hsa04510 | 1.38111854 |
21 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.35161329 |
22 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.34769144 |
23 | Adherens junction_Homo sapiens_hsa04520 | 1.32849380 |
24 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.32508053 |
25 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.31805303 |
26 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.30811454 |
27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.30539185 |
28 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.30405261 |
29 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.28513403 |
30 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.28125874 |
31 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.27097185 |
32 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.25765724 |
33 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.24250404 |
34 | Measles_Homo sapiens_hsa05162 | 1.23515338 |
35 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.22305084 |
36 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.22088626 |
37 | * Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.21817891 |
38 | Amoebiasis_Homo sapiens_hsa05146 | 1.21690790 |
39 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.20990701 |
40 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.19019476 |
41 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.18681687 |
42 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.16358865 |
43 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.15859176 |
44 | * mTOR signaling pathway_Homo sapiens_hsa04150 | 1.14426377 |
45 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.13327888 |
46 | Tuberculosis_Homo sapiens_hsa05152 | 1.13151261 |
47 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.10571819 |
48 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.10547473 |
49 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.10410340 |
50 | Hepatitis B_Homo sapiens_hsa05161 | 1.06603120 |
51 | * Insulin resistance_Homo sapiens_hsa04931 | 1.06154781 |
52 | Salmonella infection_Homo sapiens_hsa05132 | 1.05401570 |
53 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.05282308 |
54 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.05178861 |
55 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.04925955 |
56 | Malaria_Homo sapiens_hsa05144 | 1.03895903 |
57 | Colorectal cancer_Homo sapiens_hsa05210 | 1.03572027 |
58 | Shigellosis_Homo sapiens_hsa05131 | 1.03422631 |
59 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.03409804 |
60 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.02002458 |
61 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.01918931 |
62 | Endometrial cancer_Homo sapiens_hsa05213 | 1.00889833 |
63 | Influenza A_Homo sapiens_hsa05164 | 1.00068829 |
64 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.98777589 |
65 | Pertussis_Homo sapiens_hsa05133 | 0.98125472 |
66 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.98098515 |
67 | Glioma_Homo sapiens_hsa05214 | 0.96902217 |
68 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.96165971 |
69 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.93976105 |
70 | Legionellosis_Homo sapiens_hsa05134 | 0.91159305 |
71 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.90789209 |
72 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.90518426 |
73 | Apoptosis_Homo sapiens_hsa04210 | 0.89915392 |
74 | ABC transporters_Homo sapiens_hsa02010 | 0.89675544 |
75 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.89215647 |
76 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.87955310 |
77 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.87565613 |
78 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.86785377 |
79 | HTLV-I infection_Homo sapiens_hsa05166 | 0.86502677 |
80 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.86305450 |
81 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.85898360 |
82 | Thyroid cancer_Homo sapiens_hsa05216 | 0.84991107 |
83 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.84435239 |
84 | Renin secretion_Homo sapiens_hsa04924 | 0.83682908 |
85 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.83264808 |
86 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.83125187 |
87 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.82888799 |
88 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.82854659 |
89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.81451634 |
90 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.81087331 |
91 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.79295151 |
92 | Prostate cancer_Homo sapiens_hsa05215 | 0.76855771 |
93 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.76755835 |
94 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.75418071 |
95 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.75312271 |
96 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.74596596 |
97 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.74436933 |
98 | Hepatitis C_Homo sapiens_hsa05160 | 0.73072153 |
99 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.72730219 |
100 | Pathways in cancer_Homo sapiens_hsa05200 | 0.71264418 |
101 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.70617204 |
102 | Lysosome_Homo sapiens_hsa04142 | 0.70600518 |
103 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.70428691 |
104 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.69851533 |
105 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.69704357 |
106 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.69658043 |
107 | Endocytosis_Homo sapiens_hsa04144 | 0.69279633 |
108 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.69127738 |
109 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.68587019 |
110 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.68371653 |
111 | Prion diseases_Homo sapiens_hsa05020 | 0.68281359 |
112 | Histidine metabolism_Homo sapiens_hsa00340 | 0.67872422 |
113 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.67621219 |
114 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.67450524 |
115 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.66364923 |
116 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.65602469 |
117 | Allograft rejection_Homo sapiens_hsa05330 | 0.63926255 |
118 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.63855876 |
119 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.62385005 |
120 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.62176830 |
121 | Bile secretion_Homo sapiens_hsa04976 | 0.61862005 |
122 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.61482547 |
123 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.59130342 |
124 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.59083087 |
125 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.58945765 |
126 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.58746099 |
127 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.58286952 |
128 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.56605074 |
129 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.56451621 |
130 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.55498451 |
131 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.55254604 |
132 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.54727546 |
133 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.53370295 |
134 | Bladder cancer_Homo sapiens_hsa05219 | 0.50175250 |
135 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.48654733 |
136 | Galactose metabolism_Homo sapiens_hsa00052 | 0.47476201 |